How to develop sustainable patient blood management processes

September 2011
How to develop sustainable
patient blood management
processes
By Tiffany Nelson, RN
Program Coordinator for Patient Blood Management
Eastern Maine Medical Center, Bangor Maine
Agenda
• Who we are
• Our journey
• Examples of patient blood
management processes
• Challenges
• Lessons learned
EMHS – 7 Affiliated Hospitals
89 Acute Beds
72 LTC Beds
l
14 Acute Beds
36 LTC Beds
9 Swing Beds
Critical Access Hospital
l
48 Acute Beds
76 LTC Beds
l
l
l
411 Acute Beds
l
28 Acute Beds
Critical Access Hospital
25 Acute Beds
10 Swing Beds
Critical Access Hospital
100 Acute Psychiatric &
Substance Abuse Beds
Together Project Vision
Statement
All EMHS providers will be able to
treat a patient using one shared
electronic record system, no
matter where in EMHS the patient
seeks care. Information will be
instantly available; improving
patient safety, enhancing
outcomes, and saving money.
Eastern Maine Medical Center
Eastern Maine Medical Center
• 370 bed community and tertiary care
hospital in rural Maine
• Active hematology/oncology service
• Cardiac surgery program (approx. 450
cases/yr.
• High risk obstetrics
• Trauma Center
• Dialysis Center
• No transplant surgery
How We Began
• Approached administration in Summer,
2006 with concept of Blood Management
and Conservation Program with a proposal
to:
– Decrease blood acquisition costs
– Improve quality of care
• Program to be directed by the Transfusion
Service
How We Began
• Requested that start-up include:
– Full time program coordinator
– Full time Transfusion Services Medical
Director
– Resources to create a relational database in
our H.I.S. for evaluating transfusion
practices on a provider specific basis
• Program Coordinator position wasn‟t
approved until March, 2008 (filled 06/08)
• Database development is ongoing – no
dedicated resources
The Essentials: What We Did
• Education, Education, Education
• Site visit to an established program
(Englewood Hospital)
• Forging key partnerships in the O.R.
and pharmacy (Spend time in the O.R. and
pharmacy!)
• Early effort to integrate program into
the hospital information system (I.S. is
your friend!)
What We Did
• Effective implementation of transfusion
guidelines- paper order sets
• Prospective review (selective cases)
– Reinforces transfusion guidelines
• Provider “Report Cards”
• Computerized physician order
entry(CPOE)
What We Did
•
•
•
•
•
Preoperative anemia management
Perioperative blood collection program
Platelet management protocol
Minimum blood draw protocol
Inpatient anemia management by
consultation
Implementation of Transfusion
Guidelines
• Computerized Physician Order Entry (CPOE)
implemented after one year of using the
paper order set.
– Different “orderable” for each component
– Indication for transfusion a mandatory field
– Two RBC orderables: Actively Bleeding and Not
Actively Bleeding
• Only one RBC unit at a time can be ordered if
patient not actively bleeding
• Reinforces concept: each unit transfused is an
independent clinical decision
Select Transfuse Order From Menu
If RBC Anemia Non-Actively Bleeding is
chosen, only a single unit may be ordered
in an ordering “conversation”
1.
2.
3.
4.
Transfusion Rates by Period
Transfusion Rate by 'Era' and Patient Type
25%
23.2%
20%
15%
10.5%
10.4%
10.1%
9.8%
10%
7.2%
7.4%
6.4%
5.8%
5%
p<.001
p=.002
p<.001
p<.001
6.3%
5.7%
5.2%
p<.001
p<.001
p=.007
p=.008
0%
Pre
(8/062/07)
BldMng CPOE
(3/07- (12/0711/07) 12/08)
Inpatients
Pre
(8/062/07)
BldMng CPOE
(3/07- (12/0711/07) 12/08)
Surgical
Pre
(8/062/07)
BldMng CPOE
(3/07- (12/0711/07) 12/08)
Orthopedic
Pre
(8/062/07)
BldMng CPOE
(3/07- (12/0711/07) 12/08)
EMIC
Pre-op AM
Preoperative Anemia
Management
• Screen selected orthopedic procedures
for anemia/iron deficiency
• Treat anemia (e.g. I.V. iron, ESA) to optimize
Hgb prior to surgery
– Pre-op anemia is a risk factor for
perioperative transfusion
• Discourage pre-operative autologous
donations in most patients
EMMC Orthopedics Program - A Prototype
for Successful Patient Blood Management
• Preoperative anemia management
• Less invasive surgical technique with meticulous
hemostasis
• Use of anti-fibrinolytic in selected patients
• Use of perioperative cell collection and administration
(ICS and ANH, when indicated)
• Adherence to transfusion guidelines
• Optimization of oxygenation and hemodynamics
Our Outcomes for Orthopedics
Orthopedics Percent Inpatients Transfused
Transfusion rates in elective
hip and knee arthroplasty has
fallen from 25% to less than 2%
Growth and Expansion
Why expand?
• Better Quality care for patients
• Blood is a limited resource
– From 1997 to 1999 the demand for blood
increased 8.7%
– Whole blood collection decreased 11.4%
– By the year 2030, if this trend continues
there will be a RBC shortage of 4 million
units!
• Hospital economics- huge cost saving potential
with transfusion avoidance and revenue
potential for out patient anemia clinic.
What EMMC PBM Program
is Doing
• Expand pre-op anemia management program
• Developing electronic solutions
– for pre-op anemia management
– transfusion advisor
– inpatient anemia management advisor(on hold)
• Obtained AABB accreditation for peri-op
• Working with Primary Care Providers to screen and
treat anemia
• Updating our internet site for PBM
• Developing an out patient anemia clinic
Ways to expand Pre-op
Anemia Management
• Decide which procedures are at
risk for transfusion
• Implement one service at a time for
best results.
• Most PBM programs start with
orthopedics
Candidate Surgical Procedures for
Pre-operative Anemia Management
Specialty
Cardio-Thoracic
Surgical Procedure
Valve Replacement
Aortic arch aneurysm
Coronary artery bypass
Valve / CABG combo
Pneumonectomy / lobectomy
Orthopedics
Spinal fusion (> 2 levels)
Knee replacement
Hip replacement
Urology
Radical retropubic prostatectomy
Cystectomy
Nephrectomy
Neurosurgery
Giant basilar aneurysm
Cerebral aneurysm
OB/GYN
High risk pregnancy
Myomectomy (non-embolized)
Placenta accreta or previa
Abdominal hysterectomy with enlarged uterus
Breast reduction / reconstruction *
Plastics
Vascular
General
Other
Thoracoabdominal aortic aneurysm repair
Aorto-bifemoral grafts
Axillo-femoral bypass
Abdominal aortic aneurysm repair
Lower extremity revascularization
Liver resection (non-embolized)
Whipple Procedure
Splenectomy, elective
Any open abdominal procedure w/ expected blood loss >500 ml
Colectomy / Bowel resection
Any major surgical procedure for Jehovah‟s Witness
Our next service for pre-op AM
• Elective Cardiac Surgery
• Need to have surgeon buy in for program to succeed
– Shared our data from orthopedics with the CTS
surgeons
– Met with Cath lab staff and CTS office to add a
referral to PBM program for all elective surgical
cases
– Implemented process to get anemia studies
drawn either post cath or at office visit for the
surgical consult
Transfusion Rates All Cases: CABG, Valve,
CABG/Vale
Pre Op AM
23%
14%
Expand Utilizing Technology
Technology Video
Ways to expand Pre-op Anemia
Management
• Develop an electronic pre-op anemia
management tool with our IS vendor
– Began working on development of the solution in
June 2008 go live January 31, 2011
– Continue to make improvement's before it will be
ready to offer as a package to other programs
– Currently have the ability to do pre-op anemia
management for 28 procedures
LightHouse
Is a Partnership with our
clinical vendor, Cerner,
to change a care
process.
Building pathways
electronically to improve
the patient care process.
Will collect all important
data elements during the
care process.
Anemia Management M-Page
Patient Specific View of
M-Page
Patient Intervention Power Form
• Screen shot of interventions
Develop Outpatient Anemia Clinic
Epidemiology of Anemia
• Anemia is a common complication of
common diseases
• Prevalence of anemia is selected
conditions
– Rheumatoid arthritis: 30-60%
– Chronic heart failure: 30-50%
– Inflammatory bowel disease: 30-80%
– Diabetics without overt renal failure: 20-40%
– Chronic kidney disease: 40-60%
Epidemiology of Anemia
• Estimated prevalence of anemia in U.S. is 3.5
million
• Abnormal blood counts are often not
investigated
– “normative” deviation in the average PCP practice
• Economic impact
– $6.4 billion estimated annual cost in U.S.
• Quality of life impact
Virtual Anemia Management Clinic
• As our program continues to grow we
noticed many opportunities to enroll
patients in an anemia clinic.
• Our anemia clinic is still in development
stages we offer our virtual clinic to the
following patient populations
– Bariatric
– CHF
Bariatric AM Process
• Patients are referred by surgical weight loss
program via fax
• Labs obtained
– Hemogram, iron, TIBC, ferritin,B12, creatinine
• If mild anemia (hgb 11-12) and borderline iron
deficiency(TSAT 15-19 and or ferritin 75-99) start oral iron
trial with iron bisglycinate TID and folic acid 800mcg and
vitamin C 500mg bid. Re-evaluate labs in 3 months.
• If moderate to severe iron deficiency anemia we give IV iron,
usually with total dose replacement 1000-1500mg and have
them take folic acid and vitamin C also. Re-eval labs in 3
months.
Bariatric AM Process
• After labs results available the patient history is
•
•
•
•
reviewed. Dr. Gross and myself meet to discuss a
treatment plan.
Patient is called on the phone to give results of
screening and discuss the process for anemia mgt.
A consult letter is generated and sent to the patient,
the Bariatric surgeon and the PCP.
Once a maintenance dose is determined the patient
is given back to the PCP for ongoing coordination.
The patient is informed of the plan.
Bariatric AM Process
• The goal for this patient population is to
have
–
–
–
–
hgb above 12g/dl
TSAT greater than 20%
Ferritin greater than 100mg/dl
Find out what their maintenance dose to
achieve goal
• Most patients who are depended on IV iron are
needing 200-600mg ever 3-6 months
Bariatric Study-Update
Pre-Procedure Referals N=30 patients
Total Averages
Pre-op Hgb
12.5
TSAT % Ferritin Average dose IV iron
13.0
60.0 1000 mg
Percent Treated
IV Iron = 47% 49%
Oral Iron = 34%
No treatment= 17%
Post Procedure Referrals N= 78 patients
Total Averages
Baseline Hgb TSAT % Ferritin
11.2
12.0
52
Average dose IV iron
1200mg
3 Month F/U N= 44
Post Tx hgb TSAT % Ferritin
12.6
20
125
Average dose IV iron
1000mg
6 Month F/U N=18
Post Tx hgb TSAT % Ferritin
13
19
164
Average dose IV iron
600mg
Percent Treated
IV iron = 78%
oral iron=12%
No treatment= 10%
CHF Anemia Clinic
• We have contacted the cardiology
service to begin the virtual clinic
process.
– They have 500 enrolled patients with CHF
– We estimate 30-50 % have anemia and
would benefit from IV iron therapy as an
outpatient
Where are we today?
Impact of Patient Blood
Management on Outcomes
Patients Transfused
FY 1994 – FY 2010
Patients Transfused
3000
2843
2684
2422
2500
2468
2263
1998
2000
1846
1550
1737
1608
1534
1500
1000
500
0
FY 93/94 FY95/96 FY97/98 FY99/00 FY01/02 FY03/04 FY05/06 FY07/08 FY09/10
Transfuse Volume
Transfusion Volume
2006-2010
9000
8069
8000
7000
5924
6000
5000
4027
4000
3458
3389
3040
3000
2063
2000
1464
922
1000
844
958
575
839
830
397
712
1018
452
759
0
2006
2007
Red Cell Products
2008
Plasma
Platelet
Red Cells
Plasma
Platelets
Cryo
2009
Cryoprecipitate
58 % reduction
67% reduction
49% reduction
16% reduction
2010
775
Blood Acquisition Cost Savings – All
Components
• Total blood acquisition costs in FY „06 were
$3,200,000
• Cost savings compared to base year, FY ‟06*
–
–
–
–
–
FY ‟07
FY ‟08
FY ‟09
FY ‟10
Total
$ 850,000
$ 1,400,000
$ 1,600,000
$ 1,550,000
$ 5,400,000
* No change in per unit cost from blood
supplier from 2007 - 2010
Challenges and Lessons Learned
• Providers must believe the data
• Providers must be involved in selecting
correct measures
• Education, Education, Education
• Vendor collaboration is critically important in
developing safe, higher quality, efficient
functionality.
• Don‟t underestimate the internal resources
needed in development